StockData
Evofem Biosciences, Inc. logo

Evofem Biosciences, Inc. (EVFM) stock

EVFMOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.01−0.00 (-10.00%)

Close on Oct 19, 2026Market cap $865.23KP/E –Yield –

Evofem Biosciences pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Evofem Biosciences's pe ratio was 2.1× on Apr 30, 2026, against 0.3× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 20262.1×+1.9
2025Jan 31, 20250.2×−0.0
2024Dec 31, 20240.2×+0.2
2023Dec 29, 20230.0×–

More Evofem Biosciences figures

See a number that looks wrong?